# Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

> **NCT06746753** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 78 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Angiotensin II
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT06746753
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-07
- **Final completion:** 2028-08
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06746753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06746753, "Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06746753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*